12 Dec 2023

Simcere Pharmaceutical Opens ‘Hong Kong Collaborative Innovation Center’ Accelerating R&D and Translation of Innovative Drugs

Hong Kong Science and Technology Parks Corporation (HKSTP) and Simcere Pharmaceutical Group Limited (Simcere; 2096.HK), today announced the opening of the Simcere ‘Hong Kong Collaborative Innovation Center’ at the Hong Kong Science Park.

Key Takeaways

  • HKSTP will join hands with Simcere to leverage Hong Kong's unmatched connectivity with mainland China, offering a world of opportunities.
  • Listed on the HKEX in 2020, Simcere is the first batch of strategic enterprises of the Office for Attracting Strategic Enterprises (OASES) of the HKSAR Government.
  • The ‘Hong Kong Collaborative Innovation Center’ will focus on four core therapeutic areas: oncology, central nervous system, autoimmunity and anti-infection.